<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00901628</url>
  </required_header>
  <id_info>
    <org_study_id>B-0804/056-021</org_study_id>
    <nct_id>NCT00901628</nct_id>
  </id_info>
  <brief_title>Periarticular Multimodal Drug Injections in Total Knee Arthroplasty</brief_title>
  <official_title>Efficacy and Safety of Periarticular Multimodal Drug Injections in Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether periarticular multimodal drug injection
      (PMDI) would provide additional benefits in patients after total knee arthroplasty (TKA) for
      whom contemporary pain control protocols using the continuous femoral nerve block,
      intra-venous patient controlled analgesia (IV-PCA)and preemptive oral medications. We
      hypothesized that PMDI would reduce pain level and consumption of PCA and acute pain rescuer
      and would provide better functional recovery and patient satisfaction. We also hypothesized
      that the incidence of side effects and complications of the PMDI would be similar to the
      No-PMDI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The preemptive multimodal approaches are regarded as a current standard pain management
      protocol. Recently, periarticular multimodal drug injection (PMDI) has been considered to be
      one of the most effective and important component in multimodal approaches. Because the
      contemporary pain management protocol using the regional anesthesia, continuous femoral nerve
      block (FNB) and intravenous patient-controlled analgesia (PCA) has been proved significantly
      improved analgesic effects itself, little information whether the PMDI would provide
      additional pain relief under this pain management protocol is available. Also, because the
      safety of the high dose local anesthetics and narcotics has not been clarified, a selective
      application should be considered to patients who were expected to show better analgesia if
      there were certain patient related factors to predict the additional pain relief effect of
      the PMDI. Thus, this prospective double-blind randomized study was conducted to determine
      whether PMDI would provide additional benefits in patients after total knee arthroplasty
      (TKA) for whom contemporary pain control protocols using the continuous femoral nerve block,
      IV-PCA and preemptive oral medications in terms of pain relief, consumption of PCA and acute
      pain rescuer, patients satisfaction, functional recovery, side effects and complications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain( Visual Analog Scale )</measure>
    <time_frame>the night after surgery</time_frame>
    <description>An independent investigator who was blinded to randomization assessed pain level using 0 to 10 visual analog scale (VAS) that ranged from 0 (no pain) to 10 (worst imaginable pain)at the night after operation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intravenous Patient Controlled Analgesia(PCA) Consumption During 24 Hours After Surgery</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Fentanyl based PCA consumption via PCA pump (microgram)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant Number of Postoperative Nausea and Vomiting During 24 Hours After Surgery</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>An independent investigator assessed participant number of postoperative nausea and vomiting during 24 hours after surgery. Nausea was defined as a subjective unpleasant sensation associated with awareness of the urge to vomit; and vomiting, as the forceful expulsion of gastric contents from the mouth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Proportion of Patients Who Were Satisfied With the Pain Management</measure>
    <time_frame>postoperative 7 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Proportion of Patients Who Could Raise Leg With Replaced Knee Extended</measure>
    <time_frame>24 hours postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Flexion Angle Degree on Postoperative 7 Day</measure>
    <time_frame>postoperative 7 day</time_frame>
    <description>An independent investigator measured the maximal flexion angle (degree) of replaced knee with 28 centimeter armed goniometer on postoperative 7 day</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Periarticular Injection group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Injection group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>usual postoperative care without periarticular injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
    <description>300mg (0.75%, 40cc) intraoperative periarticular injection</description>
    <arm_group_label>Periarticular Injection group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine sulfate</intervention_name>
    <description>10mg intraoperative periarticular injection</description>
    <arm_group_label>Periarticular Injection group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketorolac</intervention_name>
    <description>30 mg intraoperative periarticular injection</description>
    <arm_group_label>Periarticular Injection group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epinephrine</intervention_name>
    <description>300 microgram (1:1000) intraoperative periarticular injection</description>
    <arm_group_label>Periarticular Injection group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefuroxime</intervention_name>
    <description>750mg intraoperative periarticular injection</description>
    <arm_group_label>Periarticular Injection group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of primary osteoarthritis

          -  Scheduled for elective total knee arthroplasty

          -  Signed written informed consent

          -  Spinal anesthesia

        Exclusion Criteria:

          -  Patients refusing consents

          -  inability to use the outcome assessment tools

          -  Contraindications to regional anesthesia

          -  severe cardiovascular disease

          -  allergy or contraindication to drugs used in this study

          -  pre-existing neurologic disease including psychiatric disorder

          -  drug abuser
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>81 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tae Kyun Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joint Recontruction Center, Seoul National University Bundang hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Joint Reconstruction Center, Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2009</study_first_submitted>
  <study_first_submitted_qc>May 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2009</study_first_posted>
  <results_first_submitted>May 15, 2009</results_first_submitted>
  <results_first_submitted_qc>December 15, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 25, 2013</results_first_posted>
  <last_update_submitted>December 15, 2012</last_update_submitted>
  <last_update_submitted_qc>December 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Tae Kyun Kim</investigator_full_name>
    <investigator_title>Joint reconstruction center, Dept. of orthopaedic surgery</investigator_title>
  </responsible_party>
  <keyword>periarticular multimodal drug injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Cefuroxime</mesh_term>
    <mesh_term>Cefuroxime axetil</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>101 patients who were scheduled for unilateral total knee arthroplasty recruitment at Joint Reconstruction Center, Seoul National University Bundang hospital from April 2008 to March 2009 were recruited.</recruitment_details>
      <pre_assignment_details>no participant was excluded before assignment</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Periarticular Injection Group</title>
          <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
        </group>
        <group group_id="P2">
          <title>No Injection Group</title>
          <description>usual postoperative care using the continuous femoral nerve block, IV-PCA and preemptive oral medications without periarticular injection</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>disconnection of catheter</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>disconnection of drain</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>peroneal nerve palsy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Periarticular Injection Group</title>
          <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
        </group>
        <group group_id="B2">
          <title>No Injection Group</title>
          <description>usual postoperative care without periarticular injection</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
            <count group_id="B2" value="52"/>
            <count group_id="B3" value="101"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.2" spread="7.1"/>
                    <measurement group_id="B2" value="70.1" spread="4.9"/>
                    <measurement group_id="B3" value="70.1" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Korea, Republic of</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain( Visual Analog Scale )</title>
        <description>An independent investigator who was blinded to randomization assessed pain level using 0 to 10 visual analog scale (VAS) that ranged from 0 (no pain) to 10 (worst imaginable pain)at the night after operation.</description>
        <time_frame>the night after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Periarticular Injection Group</title>
            <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
          </group>
          <group group_id="O2">
            <title>No Injection Group</title>
            <description>usual postoperative care without periarticular injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain( Visual Analog Scale )</title>
          <description>An independent investigator who was blinded to randomization assessed pain level using 0 to 10 visual analog scale (VAS) that ranged from 0 (no pain) to 10 (worst imaginable pain)at the night after operation.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="3.2"/>
                    <measurement group_id="O2" value="6.4" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intravenous Patient Controlled Analgesia(PCA) Consumption During 24 Hours After Surgery</title>
        <description>Fentanyl based PCA consumption via PCA pump (microgram)</description>
        <time_frame>24 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Periarticular Injection Group</title>
            <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
          </group>
          <group group_id="O2">
            <title>No Injection Group</title>
            <description>usual postoperative care without periarticular injection</description>
          </group>
        </group_list>
        <measure>
          <title>Intravenous Patient Controlled Analgesia(PCA) Consumption During 24 Hours After Surgery</title>
          <description>Fentanyl based PCA consumption via PCA pump (microgram)</description>
          <units>microgram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169.4" spread="273.9"/>
                    <measurement group_id="O2" value="262.3" spread="200.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participant Number of Postoperative Nausea and Vomiting During 24 Hours After Surgery</title>
        <description>An independent investigator assessed participant number of postoperative nausea and vomiting during 24 hours after surgery. Nausea was defined as a subjective unpleasant sensation associated with awareness of the urge to vomit; and vomiting, as the forceful expulsion of gastric contents from the mouth.</description>
        <time_frame>24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Periarticular Injection Group</title>
            <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
          </group>
          <group group_id="O2">
            <title>No Injection Group</title>
            <description>usual postoperative care without periarticular injection</description>
          </group>
        </group_list>
        <measure>
          <title>Participant Number of Postoperative Nausea and Vomiting During 24 Hours After Surgery</title>
          <description>An independent investigator assessed participant number of postoperative nausea and vomiting during 24 hours after surgery. Nausea was defined as a subjective unpleasant sensation associated with awareness of the urge to vomit; and vomiting, as the forceful expulsion of gastric contents from the mouth.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>the Proportion of Patients Who Were Satisfied With the Pain Management</title>
        <time_frame>postoperative 7 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Periarticular Injection Group</title>
            <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
          </group>
          <group group_id="O2">
            <title>No Injection Group</title>
            <description>usual postoperative care without periarticular injection</description>
          </group>
        </group_list>
        <measure>
          <title>the Proportion of Patients Who Were Satisfied With the Pain Management</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Proportion of Patients Who Could Raise Leg With Replaced Knee Extended</title>
        <time_frame>24 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Periarticular Injection Group</title>
            <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
          </group>
          <group group_id="O2">
            <title>No Injection Group</title>
            <description>usual postoperative care without periarticular injection</description>
          </group>
        </group_list>
        <measure>
          <title>The Proportion of Patients Who Could Raise Leg With Replaced Knee Extended</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximal Flexion Angle Degree on Postoperative 7 Day</title>
        <description>An independent investigator measured the maximal flexion angle (degree) of replaced knee with 28 centimeter armed goniometer on postoperative 7 day</description>
        <time_frame>postoperative 7 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Periarticular Injection Group</title>
            <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
          </group>
          <group group_id="O2">
            <title>No Injection Group</title>
            <description>usual postoperative care without periarticular injection</description>
          </group>
        </group_list>
        <measure>
          <title>Maximal Flexion Angle Degree on Postoperative 7 Day</title>
          <description>An independent investigator measured the maximal flexion angle (degree) of replaced knee with 28 centimeter armed goniometer on postoperative 7 day</description>
          <units>degree</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" spread="17.3"/>
                    <measurement group_id="O2" value="95.2" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>within postoperative 30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Periarticular Injection Group</title>
          <description>Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime</description>
        </group>
        <group group_id="E2">
          <title>No Injection Group</title>
          <description>usual postoperative care without periarticular injection</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>participant number of postoperative wound infection</sub_title>
                <description>A blinded investigator evaluated postoperative wound at 1 month after surgery, and assessed incidence of postoperative wound complication.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tae Kyun Kim</name_or_title>
      <organization>Joint Reconstruction Center, Seoul National University Bundang Hospital</organization>
      <phone>82-31-787-7196</phone>
      <email>osktk@snubh.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

